Skip to main content
Expertise

Elevate your expectations.

Partner with pharmaceutical market access strategy consultants who understand you.

Embark on a journey where market access for your product is more than a target—it’s an experience you can actually enjoy. At Stratenym, elevated medical communications consulting is not just a catchphrase; it’s our promise to you.

Stratenym’s formula for success.

Let’s discuss how we can help you

Plan Early

Execute Efficiently

Minimize Minutiae

+ Maximize Strategy

Market Access Success

The Stratenym Market Access Framework

Informed by years of experience on the market access front lines, we’ve developed a turnkey solution for our clients: The Stratenym Market Access Framework. The Framework incorporates our combination of strategic elements to help ensure your success.

Download our Market Access Framework

Plan early.

Our clients often seek reimbursement for products that have major holes in the evidence base needed to persuade payers. Common problems we see include:

  • Mismatch between trial endpoints and patient outcomes
  • Lack of disease-specific health state utilities
  • Missing burden-of-illness and HCRU data

Stratenym has a proven track record of helping our clients compensate for evidence gaps like these, but in many cases our earlier engagement could have identified and pre-empted such issues. To address this unmet need for our clients, we have developed our Market Access Framework to provide full end-to-end support from the pre-clinical phase to post-launch.

The sooner you bring us on board, the greater your chances of success.

Execute efficiently.

Our approach addresses three major pain points for our clients:

Managing multiple stakeholders: We help you manage your various internal and external stakeholders by taking a proactive and collaborative approach to each project. By opening up direct lines of communication with other vendors, including the economic modeling team and local experts, we save you from having to act as an information conduit. This results in more streamlined development and reduces the mistakes that happen when other vendors work in an information vacuum.

Reviewing repetitive content: Elements of the Stratenym Market Access Framework are designed to be repurposed in downstream projects, so you benefit from a consistent approach across deliverables, yielding economies of scale and reduced workload. We highlight previously approved material to save you from reviewing repetitive content, freeing you to focus on the bigger picture.

Juggling numerous deliverables: Our comprehensive approach to portfolio management ensures that all deliverables are tracked over their development cycle and benchmarked to key dates relevant to your goals. Our Market Access Framework is a road map that can be customized to any launch, and our consultants are there to guide the process every step of the way.

Collaborating with your other vendors, adaptable deliverables that reduce your reviewing load, and a bespoke market access plan that keeps your deadlines in focus—these are the ways we maximize efficiency to help our clients exceed expectations.

Minimize the minutiae.

Stratenym is uniquely positioned to provide the expertise that market access executives are seeking. Our team has the training and experience to ensure your mandate is executed to the highest level of quality, while keeping it on time and on budget.

Our internal quality control processes ensure accuracy and consistency so that you can be confident that all Stratenym documents you present to decision-makers will convey professionalism and attention to detail.

We take care of the finer details so you don’t have to.

Maximize the strategy.

With decades of experience in the pharmaceutical industry, we distill evidence, including complicated clinical trial and pharmacoeconomic data, into compelling value-driven content.

Targeting the right audience: We weave value messaging throughout each deliverable to build a holistic, compelling case tailored to payer audiences.

Understanding the data: We have the educational background to accurately interpret study methods and findings, and to pre-emptively identify gaps that payers will notice.

Demonstrating product value: We do not just regurgitate the data—we leverage the key evidence to highlight product value.

Our extensive experience in HTA and reimbursement gives us unique insight into payers’ decision-making processes and informs our general approach to market access planning. We tailor our approach to the existing evidence base, the local reimbursement context, and anticipated payer responses.

Let our industry-specific expertise amplify your product’s success in the marketplace.

Top 10 Life Science Consulting Providers in Europe 2023 award
yellow and orange stripes

Supercharge your market access communications.

We’re your partner from beginning to end, and we love the challenge of helping you achieve market access success.

So, let us do the heavy lifting.

Let’s Get Writing